Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Raynaud Disease

• Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
• Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis
• Botulinum Toxin in Raynaud's Phenomenon
• A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis
• A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis
• Cold Challenge With C21 in RP
• Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)
• Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)
• Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis
• The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
• The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
• Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
• Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
• Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
• Exparel as a Nerve Block for Severe Hand Pain
• Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
• Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis
• Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis
• PORH and Response to Cold in Raynaud's Phenomenon.
• Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
• "As Required" Oral Sildenafil in Raynaud's Phenomenon
• Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
• Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
• Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis
• Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
• A Two-Part Study of BOTOX® Therapy for Ischemic Digits
• Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
• Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
• Botulinum Toxin in the Treatment of Raynaud's
• A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
• PF-00489791 For The Treatment Of Raynaud's
• Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
• MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison
• Tadalafil for the Treatment of Raynaud's
• Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
• Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
• Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
• A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
• Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
• A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
• Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
• Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
• Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
• St. John's Wort in the Treatment of Raynaud's Phenomenon
• Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
• Lab Study of MQX-503 in Treatment of Raynaud's
• Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
• Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
• Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
• Raynaud's Treatment Study (RTS)